← Eichor
Study identifier: NCT06059872 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Biomarkers of Reaction To HIIT Exercise

Condition: Stroke · Stroke Rehabilitation · Lower Extremity Weakness, Spastic  ·  Sponsor: VA Office of Research and Development

PhaseNA
Planned participants55
Who can joinAll sexes, 18 Years to 89 Years
Healthy volunteersNo

About this study

Stroke survivors with lower limb disability can improve their walking speed with high-intensity interval training (HIIT) rehabilitation therapy. However, some individuals may not respond to HIIT even when fully adherent to the program. To address this, the investigators propose to build a predictive model that identifies if a Veteran with chronic subcortical stroke will improve their walking speed with HIIT by incorporating blood lactate as an early predictor of exercise response, and inhibitory neurotransmitter gamma-aminobutyric acid (GABA) and regional cerebral blood flow (CBF) as predictors of the brain's potential to respond, while also taking into consideration other factors such as comorbidities, demographics, and fitness levels.

This description comes directly from the study's public registry record.

Talk to the study team

Lisa C Krishnamurthy, PhD  ·  (404) 321-6111  ·  Lisa.Krishnamurthy@va.gov

Always discuss trial participation with your own doctor first.

Locations (1)

Atlanta VA Medical and Rehab Center, Decatur, GADecatur, Georgia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06059872